Logo image of VXZ

IPATH SER B S&P 500 VIX M/T (VXZ) Stock Overview

USA - NYSEARCA:VXZ - US06748M1889 - ETF

55.75 USD
+0.14 (+0.25%)
Last: 9/12/2025, 8:24:48 PM
Fundamental Rating

2

VXZ gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 391 industry peers in the Banks industry. Both the profitability and financial health of VXZ have multiple concerns. While showing a medium growth rate, VXZ is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

VXZ had positive earnings in the past year.
In the past year VXZ has reported a negative cash flow from operations.
In the past 5 years VXZ has always been profitable.
Of the past 5 years VXZ 4 years had a positive operating cash flow.
VXZ Yearly Net Income VS EBIT VS OCF VS FCFVXZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B

1.2 Ratios

VXZ has a worse Return On Assets (0.33%) than 82.35% of its industry peers.
With a Return On Equity value of 7.00%, VXZ is not doing good in the industry: 63.17% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA 0.33%
ROE 7%
ROIC N/A
ROA(3y)0.32%
ROA(5y)0.31%
ROE(3y)6.92%
ROE(5y)6.46%
ROIC(3y)N/A
ROIC(5y)N/A
VXZ Yearly ROA, ROE, ROICVXZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6 8

1.3 Margins

VXZ's Profit Margin of 17.31% is on the low side compared to the rest of the industry. VXZ is outperformed by 70.08% of its industry peers.
In the last couple of years the Profit Margin of VXZ has grown nicely.
VXZ does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 17.31%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.74%
PM growth 5Y11.07%
GM growth 3YN/A
GM growth 5YN/A
VXZ Yearly Profit, Operating, Gross MarginsVXZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

More info and screens

1

2. Health

2.1 Basic Checks

VXZ does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for VXZ has been reduced compared to 1 year ago.
The number of shares outstanding for VXZ has been reduced compared to 5 years ago.
VXZ has about the same debt/assets ratio as last year.
VXZ Yearly Shares OutstandingVXZ Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B
VXZ Yearly Total Debt VS Total AssetsVXZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500B 1T 1.5T

2.2 Solvency

A Debt/Equity ratio of 3.86 is on the high side and indicates that VXZ has dependencies on debt financing.
The Debt to Equity ratio of VXZ (3.86) is worse than 94.63% of its industry peers.
Industry RankSector Rank
Debt/Equity 3.86
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC6.3%
VXZ Yearly LT Debt VS Equity VS FCFVXZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
VXZ Yearly Current Assets VS Current LiabilitesVXZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

More info and screens

4

3. Growth

3.1 Past

VXZ shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 42.12%, which is quite impressive.
VXZ shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 11.00% yearly.
VXZ shows a small growth in Revenue. In the last year, the Revenue has grown by 5.48%.
The Revenue has been growing slightly by 5.03% on average over the past years.
EPS 1Y (TTM)42.12%
EPS 3Y0.56%
EPS 5Y11%
EPS Q2Q%51.32%
Revenue 1Y (TTM)5.48%
Revenue growth 3Y7.87%
Revenue growth 5Y5.03%
Sales Q2Q%-52.04%

3.2 Future

Based on estimates for the next years, VXZ will show a small growth in Earnings Per Share. The EPS will grow by 7.97% on average per year.
The Revenue is expected to grow by 3.56% on average over the next years.
EPS Next Y8.58%
EPS Next 2Y15.2%
EPS Next 3Y14.7%
EPS Next 5Y7.97%
Revenue Next Year8.41%
Revenue Next 2Y6.45%
Revenue Next 3Y5.44%
Revenue Next 5Y3.56%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
VXZ Yearly Revenue VS EstimatesVXZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 10B 20B 30B
VXZ Yearly EPS VS EstimatesVXZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1 2 3

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 21.61, VXZ is valued on the expensive side.
VXZ's Price/Earnings ratio is rather expensive when compared to the industry. VXZ is more expensive than 81.84% of the companies in the same industry.
The average S&P500 Price/Earnings ratio is at 27.30. VXZ is valued slightly cheaper when compared to this.
With a Price/Forward Earnings ratio of 18.98, VXZ is valued on the expensive side.
77.75% of the companies in the same industry are cheaper than VXZ, based on the Price/Forward Earnings ratio.
VXZ's Price/Forward Earnings ratio indicates a similar valuation than the S&P500 average which is at 22.73.
Industry RankSector Rank
PE 21.61
Fwd PE 18.98
VXZ Price Earnings VS Forward Price EarningsVXZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VXZ Per share dataVXZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates VXZ does not grow enough to justify the current Price/Earnings ratio.
A more expensive valuation may be justified as VXZ's earnings are expected to grow with 14.70% in the coming years.
PEG (NY)2.52
PEG (5Y)1.96
EPS Next 2Y15.2%
EPS Next 3Y14.7%

More info and screens

3

5. Dividend

5.1 Amount

VXZ has a Yearly Dividend Yield of 2.24%. Purely for dividend investing, there may be better candidates out there.
VXZ's Dividend Yield is slightly below the industry average, which is at 3.56.
VXZ's Dividend Yield is comparable with the S&P500 average which is at 2.45.
Industry RankSector Rank
Dividend Yield 2.24%

5.2 History

On average, the dividend of VXZ grows each year by 6.61%, which is quite nice.
VXZ is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)6.61%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

The dividend of VXZ is growing, but earnings are growing more, so the dividend growth is sustainable.
DPN/A
EPS Next 2Y15.2%
EPS Next 3Y14.7%
VXZ Yearly Income VS Free CF VS DividendVXZ Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B

More info and screens

IPATH SER B S&P 500 VIX M/T

NYSEARCA:VXZ (9/12/2025, 8:24:48 PM)

55.75

+0.14 (+0.25%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)07-29 2025-07-29/bmo
Earnings (Next)10-22 2025-10-22
Inst Owners51.51%
Inst Owner Change15.51%
Ins Owners0.14%
Ins Owner ChangeN/A
Market Cap195.77B
Analysts79.09
Price Target62.14 (11.46%)
Short Float %0%
Short Ratio2.9
Dividend
Industry RankSector Rank
Dividend Yield 2.24%
Yearly Dividend0.87
Dividend Growth(5Y)6.61%
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)15.23%
Min EPS beat(2)13.75%
Max EPS beat(2)16.7%
EPS beat(4)4
Avg EPS beat(4)29.84%
Min EPS beat(4)13.75%
Max EPS beat(4)64.16%
EPS beat(8)8
Avg EPS beat(8)28.97%
EPS beat(12)12
Avg EPS beat(12)22.72%
EPS beat(16)16
Avg EPS beat(16)27.45%
Revenue beat(2)2
Avg Revenue beat(2)2.74%
Min Revenue beat(2)1.38%
Max Revenue beat(2)4.11%
Revenue beat(4)4
Avg Revenue beat(4)2.75%
Min Revenue beat(4)1.38%
Max Revenue beat(4)4.11%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-3.16%
PT rev (3m)-4.57%
EPS NQ rev (1m)-3.14%
EPS NQ rev (3m)-9.21%
EPS NY rev (1m)-1.59%
EPS NY rev (3m)-0.93%
Revenue NQ rev (1m)-1.93%
Revenue NQ rev (3m)-1.46%
Revenue NY rev (1m)0.75%
Revenue NY rev (3m)0.93%
Valuation
Industry RankSector Rank
PE 21.61
Fwd PE 18.98
P/S 4.72
P/FCF N/A
P/OCF N/A
P/B 1.91
P/tB 2.14
EV/EBITDA N/A
EPS(TTM)2.58
EY4.63%
EPS(NY)2.94
Fwd EY5.27%
FCF(TTM)-3.91
FCFYN/A
OCF(TTM)-3.91
OCFYN/A
SpS11.81
BVpS29.21
TBVpS26.06
PEG (NY)2.52
PEG (5Y)1.96
Profitability
Industry RankSector Rank
ROA 0.33%
ROE 7%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 17.31%
GM N/A
FCFM N/A
ROA(3y)0.32%
ROA(5y)0.31%
ROE(3y)6.92%
ROE(5y)6.46%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-12.74%
PM growth 5Y11.07%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 3.86
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score5
WACC6.3%
ROIC/WACCN/A
Cap/Depr(3y)89.52%
Cap/Depr(5y)85.55%
Cap/Sales(3y)5.72%
Cap/Sales(5y)5.94%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)42.12%
EPS 3Y0.56%
EPS 5Y11%
EPS Q2Q%51.32%
EPS Next Y8.58%
EPS Next 2Y15.2%
EPS Next 3Y14.7%
EPS Next 5Y7.97%
Revenue 1Y (TTM)5.48%
Revenue growth 3Y7.87%
Revenue growth 5Y5.03%
Sales Q2Q%-52.04%
Revenue Next Year8.41%
Revenue Next 2Y6.45%
Revenue Next 3Y5.44%
Revenue Next 5Y3.56%
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-25.18%
FCF growth 3Y-51.04%
FCF growth 5YN/A
OCF growth 1Y-25.18%
OCF growth 3Y-47.42%
OCF growth 5YN/A